DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0007134 | Renal Cell Carcinoma | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C0036439 | Scoliosis, unspecified | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C0029401 | Osteitis Deformans | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C0338451 | Frontotemporal dementia | GNE | 10020 | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Q9Y223 |
C1332206 | Adult Lymphoma | PIGK | 10026 | phosphatidylinositol glycan anchor biosynthesis class K | Q92643 |
C0024299 | Lymphoma | PIGK | 10026 | phosphatidylinositol glycan anchor biosynthesis class K | Q92643 |
C2239176 | Liver carcinoma | PIGK | 10026 | phosphatidylinositol glycan anchor biosynthesis class K | Q92643 |
C0009402 | Colorectal Carcinoma | PIGK | 10026 | phosphatidylinositol glycan anchor biosynthesis class K | Q92643 |
C0027651 | Neoplasms | PIGK | 10026 | phosphatidylinositol glycan anchor biosynthesis class K | Q92643 |
C0006826 | Malignant Neoplasms | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C1306459 | Primary malignant neoplasm | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0007847 | Malignant tumor of cervix | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C4048328 | cervical cancer | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0024312 | Lymphopenia | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0027651 | Neoplasms | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0376358 | Malignant neoplasm of prostate | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0014859 | Esophageal Neoplasms | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0678222 | Breast Carcinoma | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0006142 | Malignant neoplasm of breast | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0027819 | Neuroblastoma | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0004509 | Azoospermia | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0028754 | Obesity | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0003873 | Rheumatoid Arthritis | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0023787 | Lipodystrophy | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C2239176 | Liver carcinoma | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024